Fulvestrant ici182 780
Fulvestrant (ICI182,780) is a selective estrogen receptor down-regulator (SERD) that is used as a laboratory tool for research purposes. It functions by binding and degrading the estrogen receptor, thereby inhibiting estrogen-mediated signaling pathways.
Lab products found in correlation
8 protocols using fulvestrant ici182 780
Endocrine Disruptors and Nuclear Receptors
Endocrine Disrupting Chemical Screening
Epithelial-Mesenchymal Transition Regulation
Receptor Binding Assay Protocol
Characterization of Immortalized Human Biliary Epithelial Cells
Glucocorticoid Receptor Modulation Pathway
Ovarian Cancer Cell Line Responses to Estrogen and BPA
17β-Estradiol, BPA, and ICI 182,780 (fulvestrant) were purchased from Sigma-Aldrich (St Louis, Missouri). Cells were treated with 1, 5, or 10 nmol/L estradiol or 10, 25, or 50 nmol/L BPA for 24 hours. Where indicated, the ER inhibitor ICI was added at 10 nmol/L. All treatments were for 24 hours, and 95% ethanol (0.1%) was used as the vehicle control.
Exploring Receptor Signaling Pathways
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!